Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Infectious Disease Physician in New York, NY
NPI: 1467520965Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Trustees of Columbia University in the City of New York
columbiadoctors.org
HQ Phone
Get M.D. Magdalena's Phone Numberphone_androidMobile
Get M.D. Magdalena's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
2000 - 2025
American Board of Internal Medicine
Infectious Disease
Harvard
BA • Department of Germanic Languages and Literatures
1990 - 1998
Columbia University Mailman School of Public Health
MPH • Epidemiology
2003 - 2006
New York Presbyterian Hospital (Columbia Campus)
Fellowship • Infectious Disease
2002 - 2005
Chief Residency • Internal Medicine
2001 - 2002
Residency • Internal Medicine
1998 - 2001
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
Medical School
Until 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 17 | 17 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 17 | 26 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 12 | 13 |
Authors: Paul Lee, Elaine Fleck, Aury Garcia, Ian Kronish, Nadia Liyanage-Don, Nathalie Moise, Jessica Singer, Paul Lee, Yifei Sun, Neil Schluger, Siqin Ye
Journal: J Gen Intern Med
Publication Date: 2021-01-14
[Urinary tract infections].
Authors: Margarita Bidegain
Lead Sponsor: David Ho
Collaborators: Henry M. Jackson Foundation for the Advancement of Military Medicine, US Military HIV Research Program, National Institute of Allergy and infectious Diseases (NIAID)/Vaccine Research Center (VRC)
Intervention / Treatment: DRUG: VRC07-523LS, DRUG: ART, DRUG: 10E8.4/iMab
Lead Sponsor: Columbia University
Intervention / Treatment: OTHER: COVID-19 Serology, BEHAVIORAL: Health Care Worker Survey
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Intervention / Treatment: BIOLOGICAL: 10-1074, BIOLOGICAL: PGT121, BIOLOGICAL: PGDM1400, BIOLOGICAL: VRC07-523LS
